Mesoblast stem cell therapy meets goal of pediatric Graft vs. Host study – Reuters
Yahoo7 News |
Mesoblast stem cell therapy meets goal of pediatric Graft vs. Host study
Reuters In patients who receive an allogeneic (from a healthy donor) bone marrow transplant for conditions such as blood cancers, donor cells may attack the recipient causing aGVHD, which activates an inflammatory response by the immune system and potential … Primary Endpoint Successfully Achieved in Mesoblast's Phase 3 Cell Therapy Trial for Acute Graft Versus Host Disease |
